An excellent new drug R&Dteam, with the matching laboratory and equipments, can fully guarantee the development of our scientific research projects. Selecting the anti-malaria series as our R&D direction, we have developed artemether, dihydroartemisinin, artesunate and lumefantrine etc. and completed the commercial production. Meanwhile, we also attach great importance to cooperate with universities and research institutions, and have entered a comprehensive cooperation of key projects with China Pharmaceutical University and Zhejiang University of Technology. By doing so, we have accumulated rich experience in R&D and created a virtuous circle with different stages but continuous development.